Literature DB >> 3784985

Extraneural metastases from medulloblastoma: long-term survival after sequentially scheduled chemotherapy and radiotherapy.

D H Mahoney, C P Steuber, J F Sandbach, D J Fernbach.   

Abstract

Extraneural relapse of medulloblastoma is an uncommon event which has typically been associated with a fatal outcome. We present a case of a 2 1/2-year-old male who developed extensive bone marrow and bone metastases 19 months after diagnosis and treatment of a medulloblastoma. This patient was successfully treated with a sequentially scheduled combination of vincristine, cyclophosphamide, and doxorubicin and remained free of disease for more than 5 years from the time of relapse.

Entities:  

Mesh:

Year:  1986        PMID: 3784985     DOI: 10.1002/mpo.2950140611

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  6 in total

1.  Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma.

Authors:  Carlos Kamiya-Matsuoka; David Cachia; Steven G Waguespack; Christopher H Crane; Anita Mahajan; Paul D Brown; Joo Yeon Nam; Ian E McCutcheon; Marta Penas-Prado
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

2.  Secondary manifestation of medulloblastoma: metastases and local recurrences in 66 patients.

Authors:  U Sure; H Bertalanffy; S Isenmann; S Brandner; W J Berghorn; W Seeger; A Aguzzi
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

3.  Extraneural metastatic medulloblastoma in an adult.

Authors:  Merideth M Wendland; Dennis C Shrieve; Gordon A Watson; Steven S Chin; Deborah T Blumenthal
Journal:  J Neurooncol       Date:  2006-04-06       Impact factor: 4.130

4.  A rare case of adult medulloblastoma with spinal metastasis.

Authors:  K Quenum; J Ntalaja; J Onen; Y Arkha; S Derraz; A El Ouahabi; S Sefiani; A Elkhamlichi
Journal:  Case Rep Neurol Med       Date:  2012-09-30

5.  Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse?

Authors:  E Bouffet; F Doz; M C Demaille; P Tron; H Roche; D Plantaz; A Thyss; J L Stephan; O Lejars; E Sariban; M Buclon; J M Zücker; M Brunat-Mentigny; J L Bernard; J C Gentet
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

6.  Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes.

Authors:  Alexander V Andriyanov; Erez Koren; Yechezkel Barenholz; S Nahum Goldberg
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.